FXI: The Prospects For Chinese Stocks (Rating Upgrade)

The iShares China Large-Cap ETF (FXI) has rallied 87.6% since January 2024 lows, outperforming U.S. indices, driven by its significantly lower valuation (P/E 10.62x) compared to U.S. markets, easing U.S.-China trade tensions, and anticipated declining U.S. interest rates. While offering a compelling value and diversification opportunity, the investment carries substantial risks stemming from China's political system and potential for abrupt policy shifts, persistent geopolitical friction, and the ongoing threat of adverse U.S. regulatory actions like tariffs or delisting, necessitating a careful risk-reward assessment.

Analysis

The iShares China Large-Cap ETF (FXI) has demonstrated significant strength, rallying 87.6% from its January 2024 low and outperforming major U.S. indices during this period. The primary driver for this momentum is a compelling valuation case; FXI's blended price-to-earnings ratio of 10.62x stands at a considerable discount to the SPY (17.86x) and QQQ (22.70x). This valuation gap is complemented by a favorable macroeconomic backdrop, including easing U.S.-China trade tensions and market anticipation of declining U.S. interest rates in 2026. Technically, the ETF exhibits a clear bullish trend of higher lows and higher highs, earning an 'A' grade for momentum. However, this positive outlook is counterbalanced by substantial, specific risks. The Chinese government's direct control over its economy introduces the potential for sudden policy shifts that can impact corporate performance. Furthermore, persistent geopolitical friction, particularly regarding Taiwan, and the risk of renewed U.S. tariffs or delisting actions, contribute to a low 'D-' risk grade for the ETF, demanding a careful assessment from investors.

Key Decisions for Investors

• Given the compelling valuation discount and strong technical momentum, investors could consider FXI for portfolio diversification, but should be mindful of the high 0.74% expense ratio.
• A disciplined approach of accumulating positions during periods of price weakness, such as near the noted April 2025 support level of $29.20, may be a prudent strategy to mitigate entry risk.
• Investors must closely monitor developments in U.S.-China relations and Chinese domestic economic policy, as these geopolitical and political factors are the primary source of risk and could rapidly alter the investment thesis.